132 related articles for article (PubMed ID: 1647414)
1. Sarcoplasmic reticulum-associated cyclic adenosine 5'-monophosphate phosphodiesterase activity in normal and failing human hearts.
Movsesian MA; Smith CJ; Krall J; Bristow MR; Manganiello VC
J Clin Invest; 1991 Jul; 88(1):15-9. PubMed ID: 1647414
[TBL] [Abstract][Full Text] [Related]
2. Calcium uptake by sarcoplasmic reticulum and its modulation by cAMP-dependent phosphorylation in normal and failing human myocardium.
Movsesian MA
Basic Res Cardiol; 1992; 87 Suppl 1():277-84. PubMed ID: 1323264
[TBL] [Abstract][Full Text] [Related]
3. Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.
Movsesian MA; Colyer J; Wang JH; Krall J
J Clin Invest; 1990 May; 85(5):1698-702. PubMed ID: 2139670
[TBL] [Abstract][Full Text] [Related]
4. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic and sarcoplasmic reticulum-associated low Km, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium.
Smith CJ; Krall J; Manganiello VC; Movsesian MA
Biochem Biophys Res Commun; 1993 Jan; 190(2):516-21. PubMed ID: 8381278
[TBL] [Abstract][Full Text] [Related]
6. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
7. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
Lugnier C; Muller B; Le Bec A; Beaudry C; Rousseau E
J Pharmacol Exp Ther; 1993 Jun; 265(3):1142-51. PubMed ID: 8389853
[TBL] [Abstract][Full Text] [Related]
8. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure.
Schmidt U; Hajjar RJ; Helm PA; Kim CS; Doye AA; Gwathmey JK
J Mol Cell Cardiol; 1998 Oct; 30(10):1929-37. PubMed ID: 9799647
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
[TBL] [Abstract][Full Text] [Related]
10. Subcellular distribution of high-affinity type IV cyclic AMP phosphodiesterase activities in rabbit ventricular myocardium: relations to post-natal maturation.
Kithas PA; Artman M; Thompson WJ; Strada SJ
J Mol Cell Cardiol; 1989 May; 21(5):507-17. PubMed ID: 2550653
[TBL] [Abstract][Full Text] [Related]
11. LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.
Kauffman RF; Crowe VG; Utterback BG; Robertson DW
Mol Pharmacol; 1986 Dec; 30(6):609-16. PubMed ID: 2946929
[TBL] [Abstract][Full Text] [Related]
12. Sarcoplasmic reticular Ca2+ pump ATPase activity in congestive heart failure due to myocardial infarction.
Afzal N; Dhalla NS
Can J Cardiol; 1996 Oct; 12(10):1065-73. PubMed ID: 9191500
[TBL] [Abstract][Full Text] [Related]
13. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy.
Movsesian MA; Bristow MR; Krall J
Circ Res; 1989 Oct; 65(4):1141-4. PubMed ID: 2551528
[TBL] [Abstract][Full Text] [Related]
15. Subcellular distribution of high-affinity type IV cyclic AMP phosphodiesterase activity in rabbit ventricular myocardium: relations to the effects of cardiotonic drugs.
Kithas PA; Artman M; Thompson WJ; Strada SJ
Circ Res; 1988 Apr; 62(4):782-9. PubMed ID: 2832097
[TBL] [Abstract][Full Text] [Related]
16. Purification, properties and polyclonal antibodies for the particulate, low Km cAMP phosphodiesterase from bovine adipose tissue.
Degerman E; Manganiello VC; Newman AH; Rice KC; Belfrage P
Second Messengers Phosphoproteins; 1988; 12(4):171-82. PubMed ID: 2854560
[TBL] [Abstract][Full Text] [Related]
17. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
Simmons MA; Hartzell HC
Mol Pharmacol; 1988 Jun; 33(6):664-71. PubMed ID: 2454387
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
Yu H; Cai JJ; Lee HC
Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
[TBL] [Abstract][Full Text] [Related]
19. Effect of ryanodine on sarcoplasmic reticulum Ca2+ accumulation in nonfailing and failing human myocardium.
Nimer LR; Needleman DH; Hamilton SL; Krall J; Movsesian MA
Circulation; 1995 Nov; 92(9):2504-10. PubMed ID: 7586351
[TBL] [Abstract][Full Text] [Related]
20. Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjects.
Silver PJ; Allen P; Etzler JH; Hamel LT; Bentley RG; Pagani ED
Second Messengers Phosphoproteins; 1990; 13(1):13-25. PubMed ID: 2286932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
